• Consensus Definition Of ‘Treatment-Resistant Depression’ For Regulatory Trials

    Clinical Research News | Hundreds of clinical trials are underway testing therapies for treatment-resistant depression (TRD), yet until very recently there was not a clear definition of what is even being treated. But with newly proposed criteria to describe the condition, researchers and regulatory agencies have a basis for agreement that could help inform study design and potentially improve the lives of millions of people worldwide.

    Mar 23, 2022

  • Addressing the Importance of Biospecimen Collection Protocols and Quality Control Processes for Downstream Analysis

    Clinical Research News | Following a standard protocol when collecting biospecimens and conducting a quality review to confirm that you are working on appropriate samples are critically important processes for downstream analysis in medical research. If biospecimens are not collected and processed in the same way, subject to the same quality controls, diagnosis verification, and clinical data collection, researchers will not be able to determine whether data outliers are due to disease progression or process inconsistencies.

    Mar 18, 2022

  • Merck Employs Virtual Reality To Combat Burden Of Long Study Visits

    Clinical Research News | As Merck recently learned, relationships with scientific leaders and outside experts can be critical to enhancing the pediatric patient experience. That was one of the take-home messages from a case study on how the company executed on a virtual reality innovation that took first place honors during Participant Engagement Award ceremonies at the recent Summit for Clinical Ops Executives (SCOPE).

    Mar 16, 2022

  • New Pan-Cancer Prognostic Score Outperforms Existing Tools

    Clinical Research News | Roche has developed a pan-cancer prognostic scoring system useful for predicting patient survival in clinical trials and monitoring treatment progress over time. The score comprises 27 routinely collected clinical parameters and outperforms all other existing scores in every study phase, according to Anna Bauer-Mehren, data science lead for Roche Pharmaceutical Research and Early Development in Germany.

    Mar 15, 2022